INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Teva Pharmaceuticals Investors Concerning...
09 Novembre 2016 - 4:30PM
Business Wire
Law Offices of Howard G. Smith announces an investigation
on behalf of investors of Teva Pharmaceuticals (“Teva” or the
“Company”) (NYSE: TEVA) concerning recent reports that the Company
has unlawfully colluded with other pharmaceutical companies to fix
generic drug prices.
According to news reports United States prosecutors may file
criminal charges against Teva by the end of 2016 for suspected
price collusion.
Bloomberg News has reported that the “antitrust investigation by
the Justice Department, begun about two years ago, now spans more
than a dozen companies and about two dozen drugs, according to
people familiar with the matter. The grand jury probe is
examining whether some executives agreed with one another to raise
prices, and the first charges could emerge by the end of the year,
they said.”
The companies identified as targets or relevant parties in the
United States investigation include Mylan NV, Teva Pharmaceutical
Industries Ltd, Allergan Plc, Lannett Co., Impax Laboratories Inc.,
Sun Pharmaceutical Industries Ltd., Mayne Pharma Group Ltd., Endo
International Plc and Taro Pharmaceutical Industries Ltd.
On this news, Teva stock fell $4.13 per share, or nearly 10%, to
close at $39.20 per share on November 3, 2016.
If you purchased Teva securities, have information or would like
to learn more about these claims, or have any questions concerning
this announcement or your rights or interests with respect to these
matters, please contact Howard G. Smith, Esquire, of Law Offices of
Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem,
Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at
(888) 638-4847, or by email to howardsmith@howardsmithlaw.com,
or visit our website at http://www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161109005180/en/
Law Offices of Howard G. SmithHoward G. Smith,
Esquire215-638-4847888-638-4847howardsmith@howardsmithlaw.comwww.howardsmithlaw.com
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024
